OrbiMed Advisors »

Mind Medicine Mindmed shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Mind Medicine Mindmed (MNMD) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Mind Medicine Mindmed

Tip: Access up to 7 years of quarterly data

All positions including Mind Medicine Mindmed held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mind Medicine Mindmed by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $16M 1.2M 13.39
2025-09-30 $4.3M 368k 11.79

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Eli Lilly & Co. (LLY)
Boston Scientific Corporation (BSX)
Sinovac Biotech SHS
Edwards Lifesciences (EW)
Upstream Bio (UPB)
Intuitive Surgical Com New (ISRG)
Sionna Therapeutics (SION)
Mbx Biosciences (MBX)
Argenx Se Sponsored Adr (ARGX)
Enliven Therapeutics (ELVN)
Alnylam Pharmaceuticals (ALNY)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)
Terns Pharmaceuticals (TERN)

View all positions for OrbiMed Advisors

Top funds holding Mind Medicine Mindmed

BlackRock
venBio Select Advisor
Driehaus Capital Management
Blackstone Group
Vanguard Group
State Street Corporation
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Deep Track Capital
OrbiMed Advisors
Susquehanna International
Candriam Luxembourg S.C.A.
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Mind Medicine Mindmed